Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: A prospective cohort study

Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis

(2021) Daniella Dwir et al.   SCHIZOPHRENIA BULLETIN

Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double‐blind, placebo‐controlled, clinical multi‐centre trial

(2020) Zhixing Li et al.   Early Intervention in Psychiatry

Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia

(2020) Cigdem Sahbaz et al.   PSYCHOPHARMACOLOGY

Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms

(2020) Nan Dai et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Multimodal prevention of first psychotic episode through N-acetyl-l -cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial

(2019) Stefanie J. Schmidt et al.   Early Intervention in Psychiatry

IL-2/IL-6 ratio correlates with liver function and recovery in acute liver injury patients

(2019) Yu Sun et al.   APMIS

Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations

(2018) Norbert Müller   SCHIZOPHRENIA BULLETIN

Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program

(2018) TianHong Zhang et al.   AMERICAN JOURNAL OF PSYCHIATRY

Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?

(2018) Rita Khoury et al.   SCHIZOPHRENIA RESEARCH

Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis

(2018) David R. Goldsmith et al.   BRAIN BEHAVIOR AND IMMUNITY

An Individualized Risk Calculator for Research in Prodromal Psychosis

(2016) Tyrone D. Cannon et al.   AMERICAN JOURNAL OF PSYCHIATRY

Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia

(2016) Şeref Şimşek et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis

(2016) Maiara Zeni-Graiff et al.   SCHIZOPHRENIA RESEARCH

Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion

(2016) T. H. Zhang et al.   Epidemiology and Psychiatric Sciences

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk

(2016) Paolo Fusar-Poli et al.   JAMA Psychiatry

Prodromal psychosis detection in a counseling center population in China: An epidemiological and clinical study

(2014) TianHong Zhang et al.   SCHIZOPHRENIA RESEARCH

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life

(2014) Golam M. Khandaker et al.   JAMA Psychiatry

Is T-helper type 2 shift schizophrenia-specific? Primary results from a comparison of related psychiatric disorders and healthy controls

(2013) Sonnig Sue-Whei Chiang et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms

(2013) Alexander Stojanovic et al.   PSYCHONEUROENDOCRINOLOGY

Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development

(2012) Paula A. Garay et al.   BRAIN BEHAVIOR AND IMMUNITY

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

(2012) Thomas L. Schwartz et al.   CURRENT PHARMACEUTICAL DESIGN

The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia

(2012) Kyoung-Sae Na et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

(2011) Brian J. Miller et al.   BIOLOGICAL PSYCHIATRY

Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)

(2010) Oliver Freudenreich et al.   PSYCHIATRY RESEARCH

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

(2010) Norbert Müller et al.   SCHIZOPHRENIA RESEARCH

Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia

(2008) Sinead M. O'Brien et al.   PSYCHIATRY RESEARCH